The product label: how pharmacokinetics and pharmacodynamics reach the prescriber.
about
Effect of content and format of prescription drug labels on readability, understanding, and medication use: a systematic reviewDynamic enhancement of drug product labels to support drug safety, efficacy, and effectiveness.Eplerenone: a new aldosterone receptor antagonist--are the FDAs restrictions appropriate?Disparate inclusion of older adults in clinical trials: priorities and opportunities for policy and practice change.
P2860
The product label: how pharmacokinetics and pharmacodynamics reach the prescriber.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The product label: how pharmacokinetics and pharmacodynamics reach the prescriber.
@ast
The product label: how pharmacokinetics and pharmacodynamics reach the prescriber.
@en
The product label: how pharmacokinetics and pharmacodynamics reach the prescriber.
@nl
type
label
The product label: how pharmacokinetics and pharmacodynamics reach the prescriber.
@ast
The product label: how pharmacokinetics and pharmacodynamics reach the prescriber.
@en
The product label: how pharmacokinetics and pharmacodynamics reach the prescriber.
@nl
prefLabel
The product label: how pharmacokinetics and pharmacodynamics reach the prescriber.
@ast
The product label: how pharmacokinetics and pharmacodynamics reach the prescriber.
@en
The product label: how pharmacokinetics and pharmacodynamics reach the prescriber.
@nl
P1476
The product label: how pharmacokinetics and pharmacodynamics reach the prescriber.
@en
P2093
Jogarao Gobburu
Patrick J Marroum
P304
P356
10.2165/00003088-200241030-00001
P577
2002-01-01T00:00:00Z
P6179
1020047502